Emerging as a groundbreaking approach in contemporary healthcare, somachems represent a new category of therapeutic agents. These complex molecules are created to specifically bind with biological structures, allowing for superior targeting of pathological cells while reducing damage to unaffected tissues. This specificity holds immense opportunity